Abstract:Background: Diabetic retinopathy, a major complication of diabetes mellitus, is a leading cause of sigh-loss in working age adults. Progressive loss of integrity of the retinal neurovascular unit is a central element in the disease pathogenesis. Retinal ischemia and inflammatory processes drive interrelated pathologies such as blood retinal barrier disruption, fluid accumulation, gliosis, neuronal loss and/or aberrant neovascularisation. Current treatment options are somewhat limited to late-stages of the disease where there is already significant damage to the retinal architecture arising from degenerative, edematous and proliferative pathology. New preventive and interventional treatments to target early vasodegenerative and neurodegenerative stages of the disease are needed to ensure avoidance of sight-loss. Main body: Historically, diabetic retinopathy has been considered a primarily microvascular disease of the retina and clinically it is classified based on the presence and severity of vascular lesions. It is now known that neurodegeneration plays a significant role during the pathogenesis. Loss of neurons has been documented at early stages in pre-clinical models as well as in individuals with diabetes and, in some, even prior to the onset of clinically overt diabetic retinopathy. Recent studies suggest that some patients have a primarily neurodegenerative phenotype. Retinal pigment epithelial cells and the choroid are also affected during the disease pathogenesis and these tissues may also need to be addressed by new regenerative treatments. Most stem cell research for diabetic retinopathy to date has focused on addressing vasculopathy. Pre-clinical and clinical studies aiming to restore damaged vasculature using vasoactive progenitors including mesenchymal stromal/stem cells, adipose stem cells, CD34+ cells, endothelial colony forming cells and induced pluripotent stem cell derived endothelial cells are discussed in this review. Stem cells that could replace dying neurons such as retinal progenitor cells, pluripotent stem cell derived photoreceptors and ganglion cells as well as Müller stem cells are also discussed. Finally, challenges of stem cell therapies relevant to diabetic retinopathy are considered. Conclusion: Stem cell therapies hold great potential to replace dying cells during early and even late stages of diabetic retinopathy. However, due to the presence of different phenotypes, selecting the most suitable stem cell product for individual patients will be crucial for successful treatment.

Retinal degeneration: molecular mechanisms and therapeutic strategies

Novel stem cell and gene therapy in diabetic retinopathy, age related macular degeneration, and retinitis pigmentosa

Recent Developments of Neuroprotective Agents for Degenerative Retinal Disorders.

Gene and cell-based therapies for retinal and optic nerve disease

Novel Therapeutic Approaches for the Treatment of Retinal Degenerative Diseases: Focus on CRISPR/Cas-Based Gene Editing

Bioengineering strategies for restoring vision

Adeno-associated virus vectors for retinal gene therapy in basic research and clinical studies

Drug Discovery Strategies for Inherited Retinal Degenerations

Strategies to Improve the Targeting of Retinal Cells by Non-Viral Gene Therapy Vectors

Progress in Photoreceptor Replacement Therapy for Retinal Degenerative Diseases

Update of application of olfactory ensheathing cells and stem cells/exosomes in the treatment of retinal disorders

Next generation therapeutics for retinal neurodegenerative diseases

Stem/progenitor cells and biodegradable scaffolds in the treatment of retinal degenerative diseases.

Gene therapy for inherited retinal diseases: exploiting new tools in genome editing and nanotechnology

Research Progress of Stem Cell-Derived RPE Cell Transplantation Therapy for Retinal Degenerative Diseases

Recent advances in the treatment and delivery system of diabetic retinopathy

Advances in cell therapies using stem cells/progenitors as a novel approach for neurovascular repair of the diabetic retina

Gene-Based Therapeutics for Inherited Retinal Diseases

Retinal ischemic diseases and promising therapeutic molecular targets

New Perspectives in Stem Cell Transplantation and Associated Therapies to Treat Retinal Diseases: From Gene Editing to 3D Bioprinting

Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives